SCHEMBL21100112

SCHEMBL21100112

CNc1ccc(C#N)c(N=O)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPT P10636 2/20 0.34
▸ IMPDH2 P12268 2/20 0.34
▸ SLC22A12 Q96S37 4/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ LMNA P02545 2/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ IDO1 P14902 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ APP P05067 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14046649 0.77 ALDH1A1 (0.46) ALDH1A1MAPTIMPDH2KDM4EGAA
SCHEMBL20714813 0.76 HTT (0.33) ALDH1A1MAPTSLC22A12CYP1A2CYP3A4
SCHEMBL28254037 0.76 AR (0.39) ALDH1A1MAPTIMPDH2KDM4EGAA
SCHEMBL21159847 0.73 MAOB (0.34) ALDH1A1MAPTCYP1A2CYP3A4CYP2C19
SCHEMBL12117937 0.73 ABCG2 (0.46) ALDH1A1MAPTIMPDH2SLC22A12HTT
SCHEMBL22764029 0.72 ALDH1A1 (0.31) ALDH1A1CYP3A4
SCHEMBL6125193 0.72 IDO1 (0.54) ALDH1A1SLC22A12GAALMNAIDO1
SCHEMBL6656206 0.72 TRPV4 (0.52) ALDH1A1MAPT
SCHEMBL13667299 0.72 LMNA (0.45) ALDH1A1MAPTKDM4EGAALMNA
SCHEMBL13361828 0.72 TRPV4 (0.38) ALDH1A1SLC22A12KDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2551270-B1 PYRAZOLOPYRIMIDINE DERIVATIVES FOR USE AS PI3 KINASE ANTAGONISTS UNIV CALIFORNIA (US) 2019-06-12 — — EP disclosed
Send feedback